OncoMatch/Clinical Trials/NCT05664178

Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology

Is NCT05664178 recruiting? Yes, currently enrolling (May 2026). This Phase 1/2 trial studies non-drug interventions for gastrointestinal cancer.

Phase 1/2RecruitingH. Lee Moffitt Cancer Center and Research InstituteNCT05664178Data as of May 2026

The purpose of the study is to evaluate a tele-resistance training exercise program for individuals undergoing chemotherapy for advanced upper gastrointestinal cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Gastric Cancer

Hepatocellular Carcinoma

Pancreatic Cancer

Cholangiocarcinoma

Esophageal Carcinoma

Disease stage

Required: Stage III, IV

Performance status

ECOG 0–1(Restricted strenuous activity)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Moffitt Cancer Center · Tampa, Florida

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify